Japan To Cut Leqembi Price By 15% Following Cost Effectiveness Review

Industry Groups Call For Changes

 
• By Lisa Takagi
  
Japan's CEA Scheme
Japan's CEA Scheme going through own assessment as it leads to price cuts for more new drugs including Leqembi.

More from Health Technology Assessment

More from Japan